• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUMENIS, LTD SLIMLINE EZ 200; LASER FIBER DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUMENIS, LTD SLIMLINE EZ 200; LASER FIBER DELIVERY DEVICE Back to Search Results
Catalog Number 0642-393-01
Device Problem Material Fragmentation (1261)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/11/2016
Event Type  malfunction  
Manufacturer Narrative
Lumenis investigated the event report contacting the user facility to request an incident report, service records, and a description of the event.Despite reasonable attempts to obtain investigation information from the user facility, lumenis is unable to confirm the validity of the reported event.Lumenis requested service reports from the distributor regarding the subject device, however; none were provided as they said those records would need to come from the user facility itself.It could not be determined if the subject device operated to manufacturer's specifications.A review of the subject device history records (dhr) determined that the subject device was manufactured and tested according to manufacture specifications.Should lumenis receive any new information, the safety complaint will be re-opened and investigated accordingly.Device not returned for investigation.
 
Event Description
Rupture of the laser probe (slimline ez200) at about 5 cm from its distal end.The breaking of the fiber, being endo-urological treatment, occured inside the operating channel of the flexible ureteroscope resulting in damaging the tool.The episode has also resulted in a significant prolongation of operator's time for the recovery of the distal end of the telephone base migrated fiber within the calico-pielica cavity.
 
Manufacturer Narrative
***additional information*** the mdr for this event had initially been reported as a product problem (malfunction) only.Although the doctor was able to remove the broken fiber fragments from the patients kidney and no patient harm had been reported, lumenis has changed the reported event to an adverse event in addition to the initially reported product problem (malfunction) as medical intervention was required to preclude serious injury.Device not returned.
 
Manufacturer Narrative
Correction - june-10-2018.During a re-evaluation of lumenis' reportable malfunction list (b)(4) on june-06-2018 it was found that although this event was determined to be mdr reportable as a malfunction and adverse event; re-evaluation of this event had concluded that no injury had occurred.A historical product complaint review revealed that in more than two years since this reported event there have been no reports of injury having been associated with the same malfunction.Based on the information above lumenis is changing the record of this mdr to malfunction, and lumenis is removing this event from its reportable malfunction list.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SLIMLINE EZ 200
Type of Device
LASER FIBER DELIVERY DEVICE
Manufacturer (Section D)
LUMENIS, LTD
6 hakidma street
po box 240
yokneam, 20692
IS  20692
MDR Report Key6247123
MDR Text Key64737262
Report Number3004135191-2017-00002
Device Sequence Number1
Product Code GEX
Combination Product (y/n)N
PMA/PMN Number
K140388
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 06/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Catalogue Number0642-393-01
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/29/2016
Initial Date FDA Received01/12/2017
Supplement Dates Manufacturer ReceivedNot provided
06/06/2018
Supplement Dates FDA Received05/23/2017
06/11/2018
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-